VIROCELL BIOLOGICS LTD
Company number 13033264 · Monitor this company
Executive summary
ViroCell Biologics Ltd has quickly established itself as a specialist CDMO in the high-potential gene and cell therapy sector, supported by strong equity capital and significant fixed asset investments. The company’s growth hinges on scaling manufacturing capacity, leveraging strategic partnerships, and advancing proprietary technology, while addressing risks related to cash burn, regulatory compliance, and competitive pressures. Focused execution on operational scalability and market penetration will be crucial to transition from investment phase to sustainable profitability.
Shareholders' funds
£22,672,068
Balance sheet as at 2023-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2020-11-20
- Registered office
- Frp Advisory Trading Ltd, 110 Cannon Street, London, EC4N 6EU
- Postcode
- EC4N 6EU
- Capital
- 156 GBP
- Accounts category
- Total Exemption Full
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2023-12-31
- Next due by
- 2025-12-31
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2024-12-03
- Next due by
- 2025-12-17
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 7 current · 2 resigned
Group structure
Controlled by Sartorius Stedim Biotech Gmbh (00200266) — since 2023-07-31
From persons-with-significant-control filings on the public register.
Contact details
- Website
- virocellbiologics.com
ViroCell Biologics is an innovation-driven CDMO focused exclusively on the design and GMP manufacture of lentiviral and retroviral vectors to enable novel cell and gene therapies to enter clinical trials.
Previous registered addresses 1
| Address | Changed on |
|---|---|
| VESTRY HOUSE LAURENCE POUNTNEY HILL, LONDON, EC4 0EH, UNITED KINGDOM | 2021-02-24 |
The class of 2020
41%
of the 595 companies in this sector incorporated in 2020 are still active today; 55% have since been dissolved.
A fact about the year, not a forecast for this company.